title: Home-based subcutaneous continuous glucose monitoring in 10 diabetic dogs.
abstract: A subcutaneous continuous glucose monitoring system (GlucoDay; Menarini Diagnostics) based on microdialysis was investigated for its clinical applicability in veterinary medicine. Ten diabetic dogs, referred as clinically stable, were equipped with this system and sent home for a maximum observation period of 48 hours. Time of insulin administration, feeding and other events were written in a diary and plotted afterwards in the glucose graph. Implantation of the microdialysis fibre, acceptance of the device and evaluation of individual canine glucose profiles were without complication. Based on the monitoring data, recommended treatment adjustments were given to the referring veterinarians in all 10 dogs; hypoglycaemic or prolonged hyperglycaemic episodes were detected in six dogs.
authors.affiliation: Clinic of Internal Medicine, Department for Companion Animals and Horses, Veterinary University of Vienna, 1210 Vienna, Austria. nadja.affenzeller@vetmeduni.ac.at
authors.forename: N
authors.initials: N
authors.lastname: Affenzeller
authors.forename: J G
authors.initials: JG
authors.lastname: Thalhammer
authors.forename: M
authors.initials: M
authors.lastname: Willmann
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000379:methods / Q000662:veterinary*; D003920:Diabetes Mellitus / Q000097:blood / Q000662:veterinary*; D004283:Dog Diseases / Q000097:blood*; D004285:Dogs; D005260:Female; D006943:Hyperglycemia / Q000097:blood / Q000517:prevention & control / Q000662:veterinary; D007003:Hypoglycemia / Q000097:blood / Q000517:prevention & control / Q000662:veterinary; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents